Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Targovax ASA ( (GB:0RIS) ) is now available.
Circio Holding ASA has corrected previously reported details of share and warrant allocations to its chairman, Damian Marron, in connection with a recent rights issue and private placement. Instead of the initially stated 120,000 new shares, Marron was finally allocated 115,395 new shares and an equal number of warrants through the rights issue.
In addition, Marron received a further 13,200 new shares and matching warrants as commission for his pre-subscription, slightly increasing his overall equity-linked exposure. The adjustment refines the disclosure to the market regarding insider participation in the capital raise, underscoring the company’s emphasis on accurate reporting of primary insider transactions to investors and regulators.
More about Targovax ASA
Circio Holding ASA is a Norway-based company listed on the Oslo market, operating within the life sciences and biotechnology investment space. The company is financed partly through equity transactions such as rights issues and private placements, reflecting a capital-markets focused model to support its portfolio and strategic activities.
Average Trading Volume: 4,564,984
Current Market Cap: NOK420.2M
Find detailed analytics on 0RIS stock on TipRanks’ Stock Analysis page.